FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Paul David C 		2. Issuer Name and Ticker or Trading Symbol

GLOBUS MEDICAL INC [ GMED ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chief Executive Officer
(Last)          (First)          (Middle)

VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

1/20/2015
(Street)

AUDUBON, PA 19403
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

1/22/2015 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock   3/12/2014     C    500000   A   (1) 500000   D    
Class A Common Stock   3/12/2014     G    500000   D $0.00   0   D    
Class A Common Stock   4/15/2014     C    3000000   A   (2) 3000000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy Class A Common Stock)   $24.10   1/20/2015     A      125000         (3) 1/20/2025   Class A Common Stock   125000   $0.00   125000   D    
Stock Option (Right to Buy Class A Common Stock)   $4.88                      (4) 8/6/2019   Class A Common Stock   18461     18461   D    
Stock Option (Right to Buy Class A Common Stock)   $11.87                      (5) 6/16/2020   Class A Common Stock   18461     18461   D    
Stock Option (Right to Buy Class A Common Stock)   $10.66                      (6) 10/27/2021   Class A Common Stock   18461     18461   D    
Stock Option (Right to Buy Class A Common Stock)   $15.34                      (7) 8/29/2022   Class A Common Stock   15000     15000   D    
Stock Option (Right to Buy Class A Common Stock)   $13.04                      (8) 1/24/2023   Class A Common Stock   48000     48000   D    
Stock Option (Right to Buy Class A Common Stock)   $23.95                      (9) 1/23/2024   Class A Common Stock   60000     60000   D    
Class B Common Stock   (10)   (1) 3/12/2014     C         500000   (1)     (1)   (1) Class A Common Stock   500000   $0.00   24444283   D    
Class B Common Stock   (10)   (2) 4/15/2014     C         3000000   (2)     (2)   (2) Class A Common Stock   3000000   $0.00   21444283   D    
Class B Common Stock   (10)   (10)                    (10)   (10) Class A Common Stock   1562573     1562573   I   By Paul Family Irrevocable Trust U/A 4/6/10   (11)
Class B Common Stock   (10)   (10)                    (10)   (10) Class A Common Stock   435350     435350   I   By David C. Paul Trust   (12)
Class B Common Stock   (10)   (10)                    (10)   (10) Class A Common Stock   435350     435350   I   By Sonali Paul Trust   (13)

Explanation of Responses:
( 1)  The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis upon the reporting person's gift of the shares and has no expiration date.
( 2)  The Company's Class B Common Stock converted into the Company's Class A Common Stock on a one-for-one basis at the election of the reporting person and has no expiration date.
( 3)  These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
( 4)  These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
( 5)  These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
( 6)  These options were granted on October 27, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
( 7)  These options were granted on August 29, 2012, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
( 8)  These options were granted on January 24, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
( 9)  These options were granted on January 23, 2014, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
( 10)  From the date of acquisition, the Company's Class B Common Stock converts into the Company's Class A Common Stock on a one-for-one basis (i) at the option of the holder, (ii) upon certain transfers, (iii) upon the closing of the Company's initial public offering if at that time the Company's Class B Common Stock that the holder beneficially owns is less than 10% of the aggregate number of all outstanding shares of the Company's common stock, and (iv) immediately if, at any time following the initial public offering of the Company's common stock, the Company's Class B Common Stock that the holder beneficially owns represents less than 5% of all outstanding shares of the Company's common stock.
( 11)  These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.
( 12)  These shares are held in a trust for the benefit of a child of the reporting person. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
( 13)  These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of the trust.

Remarks:
This Amendment is being filed to correct the description of the David C. Paul Trust in footnote 12. The original report erroneously stated that the reporting person's spouse is the trustee of the trust.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Paul David C
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON, PA 19403 		X X Chief Executive Officer

Signatures
/s/ David P. Creekman, Attorney-in-Fact 3/3/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Globus Medical Charts.
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Globus Medical Charts.